Antinuclear autoantibodies, complement level, hypergammaglobulinemia and spontaneous intrauterine hematoma in pregnant women

American Journal of Reproductive Immunology

Volumn 50, Issue 1, 2003, Pages 1-6

  Alijotas Reig, Jaume ^a   Izquierdo, Maximo ^a   Serra, Bernat ^a   Cusido, Ma Teresa ^a   Ribera, Miguel ^a   Carrera, Josep Ma ^a  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Antiphospholipid antibodies; Autoantibodies complement levels; Intrauterine hematomas; Pregnancy

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C4; DNA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; THYROID ANTIBODY;

ANAMNESIS; ANTIBODY SCREENING; ARTICLE; COMPLEMENT BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEMATOMA; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT MONITORING; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REAGIN TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; UTERINE BODY DISEASE;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; COMPLEMENT C4; FEMALE; HEMATOMA; HUMANS; HYPERGAMMAGLOBULINEMIA; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS; UTERINE HEMORRHAGE;

EID: 0038159547     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2003.00054.x     Document Type: Article

References (29)

1. Kitridou RC, Mintz G: Pregnancy in lupus: The fetus in SLE. In Duboi's Lupus Erythematosus, DJ Wallace, BH Hahn (eds), 4th edn. Philadelphia, Lea & Febiger, 1993, pp 508-515.
2. Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ: Pregnancy outcome and family size in systemic lupus erythematosus: A case control study. Rheumatology 1999; 38:460-465.
3. Hughes GRV: Thrombosis, abortion, cerebral diseases and lupus anticoagulant. BMJ 1983; 287:1088-1090.
4. Asherson RA, Khamastha MA, Ordi J, Derksen RHWM, Machin SJ, Path FRC et al.: The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989; 68:366-374.
5. Lynch A, Marlar MB, Murphy J, Davila G, Santos M, Rutledge J et al.: Antiphospholipid antibodies in predicting adverse pregnancy outcome. Ann Intern Med 1994; 120:470-475.
6. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N: Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993; 168:837-841.
7. Gleicher N: Autoantibodies and pregnancy loss. Lancet 1994; 343:747-748.
8. Eroglu GE, Scopelitis E: Antinuclear and antiphospholipid antibodies in healthy women with recurrent spontaneous abortion. Am J Reprod Immunol 1994; 31:1-6.
9. Baxi V, Pearlstone MM: Subchorionic hematomas and the presence of autoantibodies. Am J Obstet Gynecol 1991; 165:1423-1414.
10. Piura B, Tauber E, Dror Y, Sarov B, Buskila D, Hanoch S et al.: Antinuclear antibodies in healthy non-pregnant and pregnant women and their offspring. Am J Reprod Immunol 1991; 26:28-31.
11. Balasch J, Font J, Lopez-Soto A et al.: Antiphospholipid antibodies in unselected patients with repeated abortion. Human Reprod 1990; 5:43-46.
12. Cowchock S: Autoantibodies and pregnancy wastage. Am J Reprod Immunol 1991; 26:38-41.
13. Abramowsky CR, Gyves MT, Swineharth G, Vegos ME: Decidual vasculopathy of the placenta. N Engl J Med 1980; 303:668-672.
14. Pedersen JF, Mantoni M: Large intrauterine hematomata in threatened miscarriage. Frequency and clinical consequences. Br J Obstet Gynecol 1990; 97:75-77.
15. Abu-Yousef MM, Bleicher JJ, Williamson RA, Weiner C: Subchorionic haemorrhage: Sonographic diagnosis and clinical significance. Am J Radiol 1987; 149:737-740.
16. Mantoni M, Pedersen JF: Frequency, classification and significance of intrauterine echo-free lesions in threatened abortions. Br J Radiol 1988; 61(abst):539-540.
17. Harris EN: The Second International Anticardiolipin Standardisation Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) group. Am J Pathol 1990; 94:476-484.
18. Gleicher N, El-Roeiy A: The reproductive autoimmune failure syndrome. Am J Obstet Gynecol 1988; 159:223-227.
19. Gleicher N: Reproductive failure prior the onset of clinical autoimmune disease. Rheumatology 1999; 38:485-487.
20. Yasuda M, Takakuwa K, Higashino M, Ishii S, Kazama Y, Yoshizawa H et al.: A typical case of reproductive autoimmune failure syndrome in which a patient experienced recurrent abortion, preeclampsia, and intrauterine growth retardation. Am J Reprod Immunol 1993; 29:45-47.
21. Norberg R, Neived O, Sturfelt G: Anticardiolipin and complement activation: Relation to clinical symptoms. J Rheumatol 1987; 14:149-153.
22. Quinn PA, Petric M: Anticomplementary activity in serum of women with a history of recurrent pregnancy loss. Am J Obstet Gynecol 1988; 158:368-372.
23. Gleicher N, Friger J: IgM gammophaty and the lupus anticoagulant syndrome in habitual aborters. JAMA 1985; 253:3278-3281.
24. Tower CL, Regan L: Intrauterine haematomas in a recurrent miscarriage population. Human Reprod 2001; 16:2005-2007.
25. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
26. Kutteh WH, Ermel LD: A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35:402-407.
27. Kutteh WH, Yetman DL, Chantilis SJ, Crain J: Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: Role of heparin and aspirin. Human Reprod 1997; 12:1171-1175.
28. Rai R, Cohen H, Dave M, Regan L: Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 1997; 314:253-257.
29. Bick RL: Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: Prevalence, treatment and outcome results. DRW Metroplex recurrent miscarriage syndrome cooperative group. Clin Appl Thromb Hemost 2000; 6:115-125.